Buy Cartalax Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
Buy Cartalax Research Peptide
Supplied as a lyophilised powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA on Request
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA on Request
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
What is Cartalax?
Cartalax is a synthetic three-amino-acid peptide (Ala-Glu-Asp) from the Russian peptide bioregulator program, designed to target cartilage and connective tissue. It is studied in laboratory research for its effects on cartilage-cell signaling.
- A short synthetic peptide (Ala-Glu-Asp) from the Russian bioregulator program
- Studied in laboratory research for its effects on cartilage and connective-tissue cell signaling
- One of a family of short peptides each studied in a specific tissue type
- Investigated alongside other organ-specific bioregulators from the same program
For research use only. Not approved for human therapeutic use.
Cartalax, also known by its tripeptide designation AED (Ala-Glu-Asp) and the developmental code T-31, is a synthetic tripeptide bioregulator with the molecular formula C12H19N3O8 and an approximate molecular weight of 333.3 g/mol. Developed at the Saint Petersburg Institute of Bioregulation and Gerontology, Cartalax was designed based on peptide fractions associated with cartilaginous tissue. Its three-amino acid sequence, Ala-Glu-Asp, shares the AED core motif found in the longer tetrapeptide bioregulators Epithalon (AEDG), Cortagen (AEDP), Cardiogen (AEDR), and Bronchogen (AEDL), representing the minimal tripeptide unit within this structural series. Produced via solid-phase peptide synthesis, Cartalax is associated with chondrocyte gene expression and cartilage matrix signalling pathways.
Cartalax is a tripeptide bioregulator within the Khavinson framework. In mesenchymal stem cell preparations, the tripeptide modulated the expression of genes governing chondrogenic differentiation and cellular metabolic activity, including upregulation of IGF1 and NFκB and effects on TNKS2 within Wnt-associated signalling relevant to cartilage formation [1]. In a parallel in vitro model of mesenchymal stem cell ageing in culture, AED was reported to increase IGF1 gene expression approximately 3.5- to 5.6-fold alongside modulation of FOXO1, TERT, TNKS2 and NFκB, the expression of which otherwise declined with culture ageing [2]. At the whole-animal level, in aged rats, AED administration was associated with altered renal morphofunctional [3], making Cartalax a reference compound in preclinical connective-tissue and cellular-ageing research examining chondrogenic differentiation, regulation of IGF1 and associated gene expression, and morphofunctional changes in aged tissue.
Cartalax is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available on request.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review
Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 14 June 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Related Compounds
N-Acetyl Epitalon
Mol. Wt.
432.38 g/mol
Purity
≥98%
CAS No.
N/A (modified Epitalon form)
Prostamax
Mol. Wt.
487.51 g/mol
Purity
≥98%
CAS No.
N/A (Khavinson bioregulator)
Thymagen (Thymogen)
Mol. Wt.
333.34 g/mol
Purity
≥98%
CAS No.
53321-28-9
Select Size
Get notified when this batch is released
Enter your email and we'll let you know as soon as this product is available again.
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis and MSDS available on request.